title: Deal watch: Intra-Cellular Therapies and Takeda to develop PDE1 inhibitors for schizophrenia.
mesh_terms: D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1 / Q000037:antagonists & inhibitors*; D015195:Drug Design; D004345:Drug Industry / Q000191:economics / Q000458:organization & administration; D006801:Humans; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D012559:Schizophrenia / Q000188:drug therapy* / Q000201:enzymology / Q000503:physiopathology
chemical_list: D010726:Phosphodiesterase Inhibitors; D054677:Cyclic Nucleotide Phosphodiesterases, Type 1